MedPath

The efficacy of the Lysophosphatidylcholine for atopic dermatitis with facial acne or folliculitis: A Multicenter, Randomized, Double-blind Trial

Not Applicable
Conditions
Atopic dermatitis facial acne folliculitis
Registration Number
JPRN-UMIN000026338
Lead Sponsor
Yokohama City University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Patients who are classified as the most severe atopic dermatitis. (2)Patients who are under treatments of UV therapy or immunosuppressant drugs for atopic dermatitis. (3)Patients who need to start new antihistamines. (4)Patients taking antibiotics. (5)In addition, patients who are inappropriate as subjects defined by doctors.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath